{
    "msg": "获取章节试题成功",
    "data": {
        "test": {
            "ReturnMessage": "取数据成功",
            "APPEName": "ZY_LCZY_YTMJ",
            "GenDate": "Wed May 15 2019 02:28:19 GMT+0800 (CST)",
            "StyleItems": [
                {
                    "StyleID": 1,
                    "Style": "A1型题",
                    "Explain": "A1型题：每一道考试题下面有A、B、C、D、E五个备选答案。请从中选择一个最佳答案。",
                    "Score": 1,
                    "Type": "ATEST",
                    "SubType": "",
                    "TestCount": 16,
                    "TestItems": [
                        {
                            "Title": "8bc821a9002ee90e05d927da470d97239a4fffda602938ac16e0f58018dc7f10a13e2c14896b55ef18213a4a4a0b14cf",
                            "Explain": "氯丙嗪抗精神病作用机制与阻断中脑-边缘系统及中脑-皮层系统的多巴胺D[XB2.gif]样受体有关。",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "阻断中枢α肾上腺素受体"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "激动中枢M胆碱受体"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "抑制脑干网状结构上行激活系统"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "阻断中枢5-HT受体"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "阻断中枢多巴胺受体"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43000504,
                            "ATestID": 43000504,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "8bc821a9002ee90ed700ddeed372ebf0cb6e90b95dccc6ffdf1869030a5cd95c",
                            "Explain": "对晕动症（晕船、晕车）引起的呕吐无效。对顽固性呃逆有显著疗效。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "甲状腺危象的辅助治疗"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "精神分裂症或躁狂症"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "晕动病引起呕吐"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "加强镇痛药的作用"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "人工冬眠疗法"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43000505,
                            "ATestID": 43000505,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "6f73de2f2aca6c13c43939f795c92e2064d6e82026590e4d970a1f4cd90cfbfbf9ae4f30b50f42b8",
                            "Explain": "碳酸锂有明显抑制躁狂症作用，可以改善精神分裂症的情感障碍，治疗量时对正常人精神活动无影响，一般对严重急性躁狂患者先与氯丙嗪或氟哌啶合用，急性症状控制后再单用碳酸锂维持。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "碳酸锂"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "氢氧化铝"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "硫酸镁"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "苯妥英钠"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "氟哌啶醇"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002631,
                            "ATestID": 43002631,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "015b76d514fdac0708b49c87734b180baf8939406fc13f020800917addf922e11f04a54cc18220d8",
                            "Explain": "适应症①治疗精神病:用于控制精神分裂症或其他精神病的兴奋躁动、紧张不安、幻觉、妄想等症状，对忧郁症状及木僵症状的疗效较差。对Ⅱ型精神分裂症患者无效，甚至可加重病情。②镇吐:几乎对各种原因引起的呕吐，如尿毒症、胃肠炎、癌症、妊娠及药物引起的呕吐均有效。也可治疗顽固性呃逆。但对晕动病呕吐无效。③低温麻醉及人工冬眠:用于低温麻醉时可防止休克发生。人工冬眠时，与哌替啶、异丙嗪配成冬眠合剂用于创伤性休克、中毒性休克、烧伤、高烧及甲状腺危象的辅助治疗。④与镇痛药合用，治疗癌症晚期患者的剧痛。⑤治疗心力衰竭。⑥试用于治疗巨人症。",
                            "TestPoint": "镇静催眠药",
                            "Answer": "D",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "人工冬眠疗法"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "精神分裂症"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "药物引起的呕吐"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "晕动病引起的呕吐"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "躁狂症"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002632,
                            "ATestID": 43002632,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "d87d5420d1dccb438761f23a925aab8146f019a748bbf105e4020d56649ae6fe230aff573e7d9a134e2e700cda01a8fd795f6cc260553590",
                            "Explain": "长期大量应用时可引起锥体外系反应，为抗精神病药物常见的不良反应。由于阻断多巴胺能纹状体黑质传导途径产生震颤麻痹综合征、急性肌张力障碍、静坐不能等症状，可用苯海索对抗之，但能降低疗效。本品还可引起一种特殊持久的运动障碍，称为迟发性运动障碍，表现为不自主的刻板运动，停药后不消失，抗胆碱药可加重此反应。",
                            "TestPoint": "镇静催眠药",
                            "Answer": "C",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "帕金森综合征"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "静坐不能"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "迟发性运动障碍"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "急性肌张力障碍"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "直立性低血压"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002633,
                            "ATestID": 43002633,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "8bc821a9002ee90e47383e352d297c19130e508069becb3aeeabe40e234310d0adab0c3a3767dd167017c347f4a24ed3f8522ea9a4fa91a0",
                            "Explain": "注射或口服大剂量时可引起体位性低血压，用药后应静卧1~2小时，血压过低时可静脉滴注去甲肾上腺素或麻黄碱升压。但不可用肾上腺素，以防血压降的更低。",
                            "TestPoint": "镇静催眠药",
                            "Answer": "B",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "甲氧明"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "肾上腺素"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "去氧肾上腺素"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "去甲肾上腺素"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "间羟胺"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002634,
                            "ATestID": 43002634,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "8bc821a9002ee90e5ae76f3edd308ff1fd19d9bdb10ed7c8e9e0fd8359c9d21745922f87fc69dabd1cdd5e02cf1111fead204e1f91fb3f71",
                            "Explain": "长期大量应用时可引起锥体外系反应，为抗精神病药物常见的不良反应。由于阻断多巴胺能纹状体黑质传导途径产生震颤麻痹综合征、急性肌张力障碍、静坐不能等症状，可用苯海索对抗之，但能降低疗效",
                            "TestPoint": "镇静催眠药",
                            "Answer": "B",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "结节漏斗通路中的D[2.gif]受体"
                                },
                                {
                                    "HasImg": 1,
                                    "ItemName": "B",
                                    "Content": "黑质纹状体通路中的D[2.gif]受体"
                                },
                                {
                                    "HasImg": 1,
                                    "ItemName": "C",
                                    "Content": "中脑边缘系中的D[2.gif]受体"
                                },
                                {
                                    "HasImg": 1,
                                    "ItemName": "D",
                                    "Content": "中脑皮质通路中的D[2.gif]受体"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "中枢M胆碱受体"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002636,
                            "ATestID": 43002636,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "88fac919bba518f019175ff08c759f3f14e41526d5430995bb342dd3ca841b80c31095393bc879f72646ff63d6782664",
                            "Explain": "米帕明可能因抑制突触前膜对NA及（或）5-HT的再摄取，使突触间隙的NA浓度升高，促进突触传递功能而发挥抗抑郁作用。",
                            "TestPoint": "抗精神失常药",
                            "Answer": "D",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "促进脑内NA和5-HT释放"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "抑制脑内NA和5-HT释放"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "促进脑内NA和5-HT再摄取"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "抑制脑内NA和5-HT再摄取"
                                },
                                {
                                    "HasImg": 1,
                                    "ItemName": "E",
                                    "Content": "激活脑内D[2.gif]受体"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002637,
                            "ATestID": 43002637,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "85343b5d69e20bef0d1c03e5c446c16f9d02f0ff41d0bb248d4b3c2b883aa39756e67798404e631fd2d4e3e5f0e26adefdf8ea4f77f3cace",
                            "Explain": "氯氮平不仅对精神病阳性症状有效，对阴性症状也有一定效果。适用于急性与慢性精神分裂症的各个亚型，对幻觉妄想型、青春型效果好。也可以减轻与精神分裂症有关的情感症状（如：抑郁、负罪感、焦虑）。对一些用传统抗精神病药治疗无效或疗效不好的病人，改用本品可能有效。本品也用于治疗躁狂症或其他精神病性障碍的兴奋躁动和幻觉妄想。因导致粒细胞减少症，一般不宜作为首选药。",
                            "TestPoint": "抗精神失常药",
                            "Answer": "A",
                            "Difficulty": "很难",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "氯氮平"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "氟奋乃静"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "三氟拉嗪"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "氯丙嗪"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "硫利达嗪"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002638,
                            "ATestID": 43002638,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "b4f45204a7a755291bc3d74c70b8af546fc76bdd1f90f68915173d51814ccbcf80d7d88f1b3d49b2b39f4f0d791c7af2",
                            "Explain": "临床作用，尤其在不良反应方面各具特点，因此可供不同病例选择。该类药物已成为治疗初发急性精神分裂症的首选药物。目前，常用的药物有以下几种：利培酮(risperidone)奥氮平(olanzapine)和喹硫平(quetiapine) 阿立哌唑(aripiprazole) 齐拉西酮(ziprasidone) 2017版临床执业医师资格考试宝典特训密卷氨磺必利(amisulpride) 对难治性精神分裂症而言，不能不提氯氮平(clozapine)这一药物。在我国，氯氮平已有30年的临床使用经验，其药效机制属于非典型抗精神病药物一类，对精神分裂症的阳性和阴性症状都有较好疗效。有资料显示，其治疗难治性精神分裂症病例，有效率超过30%。然而，该药有许多严重的不良反应，如体重增加、肥胖、流涎等，其抗胆碱作用可引起口干、便秘、尿潴留，少数患者可抽搐发作，偶可诱发室性心动过速，约1％～2％的病例会因白细胞减少导致粒细胞缺乏症。因此，氯氮平不是治疗精神分裂症的一线药物。",
                            "TestPoint": "抗精神失常药",
                            "Answer": "A",
                            "Difficulty": "很难",
                            "SelectedItems": [
                                {
                                    "Content": "氯氮平",
                                    "ItemName": "A"
                                },
                                {
                                    "Content": "三氟拉嗪",
                                    "ItemName": "B"
                                },
                                {
                                    "Content": "氟哌啶醇",
                                    "ItemName": "C"
                                },
                                {
                                    "Content": "地西泮",
                                    "ItemName": "D"
                                },
                                {
                                    "Content": "泰尔登",
                                    "ItemName": "E"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002639,
                            "ATestID": 43002639,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "8bc821a9002ee90e169c7aa7d95b5e4c5cde654ca7b74f3638b56a0973e47e14483f06f5dd7b66eb8598d37e332731cd7a491ff9e75d9a93d1597864b4b65eb9ddb9ada147323a5b8e7c4d7a089d4b85",
                            "Explain": "氯丙嗪为中枢多巴胺受体的阻断剂 。小剂量可抑制延脑催吐化学敏感区的多巴胺受体，大剂量可直接抑制呕吐中枢，产生强大的镇吐作用 。但对刺激前庭所致的呕吐无效，一般不适用于晕动病所致呕吐 。故选C。",
                            "TestPoint": "肾上腺素受体阻断药",
                            "Answer": "C",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "胃肠炎"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "恶性肿瘤"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "晕动病"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "药物"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "放射病"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015416,
                            "ATestID": 43015416,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "0cc15db01838f401276768fb30f191a51dd6b0ff242b322133bfa470b95adc2221026fbe7cd29b22",
                            "Explain": "A错误，对刺激前庭引起的呕吐无效。氯丙嗪有强大的镇吐作用。但对晕动病（晕车、晕船）引起的呕吐无效。晕动病就是刺激前庭引起的呕吐。",
                            "TestPoint": "肾上腺素受体阻断药",
                            "Answer": "A",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "对刺激前庭引起的呕吐有效"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "可抑制促皮质激素的分泌"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "可加强苯二氮[caozhuo.gif]类药物的催眠作用"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "可阻断脑内多巴胺受体"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "可使正常人体温下降"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015417,
                            "ATestID": 43015417,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "b931904abaea818567fb10302ab4ab70f26168fb94753edd911509b81dc827bf96f370e73f453ef3",
                            "Explain": "①帕金森综合征，出现肌张力增高、面容呆板（面具脸）、动作迟缓、肌肉震颤、流涎等；②急性肌张力障碍，多出现于用药后1～5天，由于舌、面、颈及背部肌肉痉挛，患者出现强迫性张口、伸舌、斜颈、呼吸运动障碍及吞咽困难；③静坐不能，患者出现坐立不安，反复徘徊。不会抑制体内催乳素分泌，选B。",
                            "TestPoint": "肾上腺素受体阻断药",
                            "Answer": "B",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "帕金森综合征"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "抑制体内催乳素分泌"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "患者出现坐立不安"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "急性肌张力障碍"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "抑制促皮质激素的分泌"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015418,
                            "ATestID": 43015418,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "3fcabb1c7dedcfc6bb23642038a7448dbde85693bc71a4bc5b3284aae2c8109505eed090e86380249c1cfcf55d66a729c4b3487f74afd50fe484c193aaa565f42ff55fb8c947da81e72dc0ec5eaa970ecd653a58a93b2ae0",
                            "Explain": "肾上腺素为α和β受体激动剂，激动α受体（升高血压），激动β受体（降低血压）。但若预先给予α受体阻断药，肾上腺素的升压作用可被翻转为降压作用（α受体被阻断后，仅表现β受体激动的效应），氯丙嗪可阻断α受体，使用肾上腺素后仅表现为血压下降，心率增加。故选B。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "血压不变"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "降压"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "升压"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "心率减慢"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "心率不变"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015419,
                            "ATestID": 43015419,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "700f6b70d2ab7f41e25f52d6b61a54676e71b1f7ef2d4b516ec514933be56a6a45f72d0fcae5508d",
                            "Explain": "氯氮平：本药不仅能够拮抗中枢精神系统多巴胺2（D[XB2.gif]）受体，同时具有拮抗中枢五羟色胺2（S[XB2.gif]）受体作用，因此称之为非典型抗精神病药物 。B .氯丙米嗪（氯米帕明）：属于传统的抗抑郁、抗强迫病药物 。C .卡马西平：抗癫痫药，也属于情感稳定剂 。D .氟西汀：是新型抗抑郁药，属于选择性5羟色胺重吸收（再摄取）抑制剂（即SSRI） 。E .阿扑吗啡：是治疗酒依赖的药物 。因此，本题正确答案即：选择性5-羟色胺重吸收抑制剂应该是D--氟西汀，",
                            "TestPoint": "抗精神失常药",
                            "Answer": "A",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "氯氮平"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "氯丙咪嗪"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "卡马西平"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "氟西汀"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "阿扑吗啡"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015420,
                            "ATestID": 43015420,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "03d19fe8ec83cfe17fa40ec31a366617dd9e612596489c0b4f13c6a10bab8554b4dc82af6e8b3b344c245b1d21005e949adec3171729c37d",
                            "Explain": "苯二氮类药物可缩短入睡时间、减少觉醒时间和次数、增加总睡眠时间 。按药物的半衰期长短分为短效、中效、长效三类 。临床应用于治疗：①焦虑症及各种神经官能症 。②失眠：尤对焦虑性失眠疗效极佳 。③癫痫：可与其它抗癫痫药合用，治疗癫痫大发作或小发作，控制癫痫持续状态时应静脉注射 。④各种原因引起的惊厥：如子痫、破伤风、小儿高烧惊厥等 。⑤脑血管意外或脊髓损伤性中枢性肌强直或腰肌劳损、内镜检查等所致肌肉痉挛 。",
                            "TestPoint": "镇静催眠药",
                            "Answer": "E",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "Content": "作用部位主要在脑干网状结构",
                                    "ItemName": "A"
                                },
                                {
                                    "Content": "对大脑损伤引起的肌肉僵直无作用",
                                    "ItemName": "B"
                                },
                                {
                                    "Content": "小剂量药物无抗焦虑作用",
                                    "ItemName": "C"
                                },
                                {
                                    "Content": "停药后代偿性反跳较明显",
                                    "ItemName": "D"
                                },
                                {
                                    "Content": "对快动眼睡眠时相影响较小",
                                    "ItemName": "E"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015422,
                            "ATestID": 43015422,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        }
                    ]
                },
                {
                    "StyleID": 5,
                    "Style": "A1/A2型题",
                    "Explain": "A1/A2型题：每一道考试题下面有A、B、C、D、E五个备选答案。请从中选择一个最佳答案。",
                    "Score": 1,
                    "Type": "ATEST",
                    "SubType": "",
                    "TestCount": 1,
                    "TestItems": [
                        {
                            "Title": "3428e7a252e42e3a969eb78f6e498ea1800f2de55b61bd12295c8b4a3481dfdc5289fa97401cd178",
                            "Explain": "氯丙嗪：①抑制下丘脑体温调节中枢，使体温调节失灵，不仅降低发热者的体温，而且也能降低正常人的体温；②加强麻醉药、镇静催眠药、镇痛药及乙醇的作用；③阻断中脑。边缘通路和中脑-皮质通路的D[XB2.gif]样受体发挥抗精神病作用；④对内分泌系统也有影响，能抑制促皮质激素和生长激素的分泌；⑤对刺激前庭引起的呕吐无效。故选A。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "对刺激前庭引起的呕吐有效"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "可使正常人体温下降"
                                },
                                {
                                    "HasImg": 1,
                                    "ItemName": "C",
                                    "Content": "可加强苯二氮[zhuo.gif]类药物的催眠作用"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "可阻断脑内多巴胺受体"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "可抑制促皮质激素的分泌"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 41000515,
                            "ATestID": 41000515,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        }
                    ]
                },
                {
                    "StyleID": 3,
                    "Style": "B1型题",
                    "Explain": "B1型题：以下提供若干组考题，每组考题共用在考题前列出的A、B、C、D、E五个备选答案。请从中选择一个与问题关系最密切的答案。某个备选答案可能被选择一次、多次或不被选择。",
                    "Score": 1,
                    "Type": "BTEST",
                    "SubType": "单项",
                    "TestCount": 14,
                    "TestItems": [
                        {
                            "Title": "46d95df45777d6f46074880d31ab8ff9eea8fde027d5b84fe7cf22d9d9cc85b383e844298761719a9e78438732090072655a0163453c8196",
                            "Explain": "①地西泮具有中枢性肌肉松弛作用，临床用于缓解人类大脑损伤（去大脑强直）所致的肌肉僵直。②氯丙嗉主要作用于呕吐中枢，所以具有强大的止吐作用，对多种药物引起的呕吐及顽固性呃逆效果显著。晕动病无效。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "地西泮"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "氯丙嗪"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "异丙嗪"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "乙酰胺"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "苯妥英钠"
                                }
                            ],
                            "AllTestID": 35000550,
                            "BTestID": 35000122,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "BTestItems": [
                                {
                                    "BTestItemID": 35000122,
                                    "Title": "46d95df45777d6f46074880d31ab8ff9eea8fde027d5b84fe7cf22d9d9cc85b383e844298761719a9e78438732090072655a0163453c8196",
                                    "Explain": "①地西泮具有中枢性肌肉松弛作用，临床用于缓解人类大脑损伤（去大脑强直）所致的肌肉僵直。②氯丙嗉主要作用于呕吐中枢，所以具有强大的止吐作用，对多种药物引起的呕吐及顽固性呃逆效果显著。晕动病无效。",
                                    "TestPoint": "",
                                    "Answer": "A",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 35000123,
                                    "Title": "e606c38415b05a19010b43727f81e48011f01974a0be79d7780e9af491872ccdc4020c5c869acdd5",
                                    "Explain": "①地西泮具有中枢性肌肉松弛作用，临床用于缓解人类大脑损伤（去大脑强直）所致的肌肉僵直。②氯丙嗉主要作用于呕吐中枢，所以具有强大的止吐作用，对多种药物引起的呕吐及顽固性呃逆效果显著。晕动病无效。",
                                    "TestPoint": "",
                                    "Answer": "B",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "c45232b52c9f3e13d31bb81692692aa730c780b62fbd99d6c6a03065abae040c036df07519533f99ac6cf1b5f6173dd92f051f750e6dde34d5308dcfcfcabd441ba9a16e1003665336d65d281f8df04274743c26c1a98404",
                            "Explain": "洋地黄类药物适应证为中、重度收缩性心力衰竭患者，对心室率快速的心房颤动患者特别有效。故1题选B。预激综合征本身不需特殊治疗，并发室上性心动过速时，治疗同一般室上性心动过速，宜尽快采用同步直流电复律。利多卡因、普鲁卡因胺、普罗帕酮与胺碘酮减慢旁路的传导，可使心室率减慢或使心房颤动和心房扑动转复为窦性心律。洋地黄加速旁路传导，维拉帕米和普萘洛尔减慢房室结内传导，都可能使心室率明显增快，甚至发展成心室颤动，因而不宜使用。故2题选E。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "维拉帕米"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "洋地黄"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "利多卡因"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "地尔硫[zhuo.gif]"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "普罗帕酮"
                                }
                            ],
                            "AllTestID": 41000517,
                            "BTestID": 41000157,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "BTestItems": [
                                {
                                    "BTestItemID": 41000157,
                                    "Title": "c45232b52c9f3e13d31bb81692692aa730c780b62fbd99d6c6a03065abae040c036df07519533f99ac6cf1b5f6173dd92f051f750e6dde34d5308dcfcfcabd441ba9a16e1003665336d65d281f8df04274743c26c1a98404",
                                    "Explain": "洋地黄类药物适应证为中、重度收缩性心力衰竭患者，对心室率快速的心房颤动患者特别有效。故1题选B。预激综合征本身不需特殊治疗，并发室上性心动过速时，治疗同一般室上性心动过速，宜尽快采用同步直流电复律。利多卡因、普鲁卡因胺、普罗帕酮与胺碘酮减慢旁路的传导，可使心室率减慢或使心房颤动和心房扑动转复为窦性心律。洋地黄加速旁路传导，维拉帕米和普萘洛尔减慢房室结内传导，都可能使心室率明显增快，甚至发展成心室颤动，因而不宜使用。故2题选E。",
                                    "TestPoint": "",
                                    "Answer": "B",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 41000158,
                                    "Title": "6e5d56c24891cd65aeaf7938c2711f96e984ffeef3eae036f893516f899683034a614277b822ff9a6c51911dfc671f02575c60b93f29b06738d7802e1eeb0ad1",
                                    "Explain": "洋地黄类药物适应证为中、重度收缩性心力衰竭患者，对心室率快速的心房颤动患者特别有效。故1题选B。预激综合征本身不需特殊治疗，并发室上性心动过速时，治疗同一般室上性心动过速，宜尽快采用同步直流电复律。利多卡因、普鲁卡因胺、普罗帕酮与胺碘酮减慢旁路的传导，可使心室率减慢或使心房颤动和心房扑动转复为窦性心律。洋地黄加速旁路传导，维拉帕米和普萘洛尔减慢房室结内传导，都可能使心室率明显增快，甚至发展成心室颤动，因而不宜使用。故2题选E。",
                                    "TestPoint": "",
                                    "Answer": "E",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "700f6b70d2ab7f41e25f52d6b61a54676e71b1f7ef2d4b51794c42f1309dc1d28be8c358e87e0cb2",
                            "Explain": "利培酮、奥氮平、奎硫平是目前精神科临床广泛使用的三种非典型抗精神病药物，其中利培酮由于其疗效肯定，且锥体外系反应及运动功能抑制等药物不良反应少，因而备受关注。故1题选D。氟西汀能高度选择性抑制突触前膜对5-HT的再摄取，对去甲肾上腺素(NE)的再摄取影响很小，易通过血脑屏障进入中枢神经系统。故2题选C。碳酸锂主要用于治疗躁狂症。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "卡马西平"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "碳酸锂"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "氟西汀"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "利培酮"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "氯丙嗪"
                                }
                            ],
                            "AllTestID": 41000518,
                            "BTestID": 41000159,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "BTestItems": [
                                {
                                    "BTestItemID": 41000159,
                                    "Title": "700f6b70d2ab7f41e25f52d6b61a54676e71b1f7ef2d4b51794c42f1309dc1d28be8c358e87e0cb2",
                                    "Explain": "利培酮、奥氮平、奎硫平是目前精神科临床广泛使用的三种非典型抗精神病药物，其中利培酮由于其疗效肯定，且锥体外系反应及运动功能抑制等药物不良反应少，因而备受关注。故1题选D。氟西汀能高度选择性抑制突触前膜对5-HT的再摄取，对去甲肾上腺素(NE)的再摄取影响很小，易通过血脑屏障进入中枢神经系统。故2题选C。碳酸锂主要用于治疗躁狂症。",
                                    "TestPoint": "",
                                    "Answer": "D",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 41000160,
                                    "Title": "074256bf60ce4fa32cfa594a4bb255b6f7d7bb846be89a024604b362d0a733dc0002b6524fc51899cb4bdca071cc1d1efa7afdc430c5dc5a",
                                    "Explain": "利培酮、奥氮平、奎硫平是目前精神科临床广泛使用的三种非典型抗精神病药物，其中利培酮由于其疗效肯定，且锥体外系反应及运动功能抑制等药物不良反应少，因而备受关注。故1题选D。氟西汀能高度选择性抑制突触前膜对5-HT的再摄取，对去甲肾上腺素(NE)的再摄取影响很小，易通过血脑屏障进入中枢神经系统。故2题选C。碳酸锂主要用于治疗躁狂症。",
                                    "TestPoint": "",
                                    "Answer": "C",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "8bc821a9002ee90eb10abbad6483d3144d2587e33ff0387c581def0815a58dad",
                            "Explain": "氯丙嗪又名冬眠灵，主要阻断脑内边缘系统多巴胺受体，这是其抗精神病作用的主要机制，故1题选D。丙米嗪对心肌有奎尼丁样直接抑制作用，心血管疾病者慎用，故2题选A。碳酸锂的作用机制为抑制脑内神经突触部位去甲肾上腺素的释放并促进再摄取，故3题选B。",
                            "TestPoint": "",
                            "Answer": "D",
                            "Difficulty": "",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "对心肌有奎尼丁样作用"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "使突触间隙的去甲肾上腺素(NA)浓度下降"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "阻断N胆碱受体"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "阻断DA受体"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "阻断中枢5-HT受体"
                                }
                            ],
                            "AllTestID": 41000519,
                            "BTestID": 41000161,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "BTestItems": [
                                {
                                    "BTestItemID": 41000161,
                                    "Title": "8bc821a9002ee90eb10abbad6483d3144d2587e33ff0387c581def0815a58dad",
                                    "Explain": "氯丙嗪又名冬眠灵，主要阻断脑内边缘系统多巴胺受体，这是其抗精神病作用的主要机制，故1题选D。丙米嗪对心肌有奎尼丁样直接抑制作用，心血管疾病者慎用，故2题选A。碳酸锂的作用机制为抑制脑内神经突触部位去甲肾上腺素的释放并促进再摄取，故3题选B。",
                                    "TestPoint": "",
                                    "Answer": "D",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 41000162,
                                    "Title": "52e39c4c4bf87aa18859a455c7c55f69d9e14f13133e3d5125e0509207e48ba0",
                                    "Explain": "氯丙嗪又名冬眠灵，主要阻断脑内边缘系统多巴胺受体，这是其抗精神病作用的主要机制，故1题选D。丙米嗪对心肌有奎尼丁样直接抑制作用，心血管疾病者慎用，故2题选A。碳酸锂的作用机制为抑制脑内神经突触部位去甲肾上腺素的释放并促进再摄取，故3题选B。",
                                    "TestPoint": "",
                                    "Answer": "A",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 41000163,
                                    "Title": "40b2e5894b8d064684a326c7faf0df3075a9a0a8ff85548cf4a67782a178159e",
                                    "Explain": "",
                                    "TestPoint": "",
                                    "Answer": "B",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "7b5f7542acac4c33c6d034b5cfe5c783",
                            "Explain": "躁狂症其实也是神经异常放电所引起的，所以临床上一般会选择应用碳酸锂、氟奋乃静、氟哌丁醇、氯丙嗪和氯氮平等进行治疗，还可以有效的抑制躁狂症的发作，用药之后，还需进行心理上的疏导，多与他人沟通后，就可以有效的避免躁狂症症状的发生。",
                            "TestPoint": "镇静催眠药",
                            "Answer": "A",
                            "Difficulty": "难",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "碳酸锂"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "米帕明"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "氯丙嗪"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "奋乃静"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "五氟利多"
                                }
                            ],
                            "AllTestID": 43002630,
                            "BTestID": 43000681,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43000681,
                                    "Title": "7b5f7542acac4c33c6d034b5cfe5c783",
                                    "Explain": "躁狂症其实也是神经异常放电所引起的，所以临床上一般会选择应用碳酸锂、氟奋乃静、氟哌丁醇、氯丙嗪和氯氮平等进行治疗，还可以有效的抑制躁狂症的发作，用药之后，还需进行心理上的疏导，多与他人沟通后，就可以有效的避免躁狂症症状的发生。",
                                    "TestPoint": "镇静催眠药",
                                    "Answer": "A",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000682,
                                    "Title": "df02230bae20785aee9dcc7fa3cab461",
                                    "Explain": "抑郁症首选米帕明。",
                                    "TestPoint": "镇静催眠药",
                                    "Answer": "B",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "40b2e5894b8d064689f3a731f5463674e806636cf72a84f7df57bcd427ee2c0d",
                            "Explain": "碳酸锂作用机制为使突触间隙的Na[SBjia.gif]浓度下降。",
                            "TestPoint": "抗精神失常药",
                            "Answer": "B",
                            "Difficulty": "难",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "对心肌有奎尼丁样作用"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "使突触间隙的Na[SBjia.gif]浓度下降"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "阻断中枢5-HT受体"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "阻断D[XB1.gif]、D[XB2.gif]受体"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "增强GABA能神经传递和突触抑制"
                                }
                            ],
                            "AllTestID": 43015414,
                            "BTestID": 43002839,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 284,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43002839,
                                    "Title": "40b2e5894b8d064689f3a731f5463674e806636cf72a84f7df57bcd427ee2c0d",
                                    "Explain": "碳酸锂作用机制为使突触间隙的Na[SBjia.gif]浓度下降。",
                                    "TestPoint": "抗精神失常药",
                                    "Answer": "B",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43002840,
                                    "Title": "52e39c4c4bf87aa18c52f1b1161bb16388635a8314f4813866ed6bd0b97c0b0a",
                                    "Explain": "丙米嗪作用特点为对心肌有奎尼丁样作用。",
                                    "TestPoint": "抗精神失常药",
                                    "Answer": "A",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43002841,
                                    "Title": "8bc821a9002ee90ee8c88d8ed65a90a0a72feb1bff97bf7ee67bfa2c32692e18",
                                    "Explain": "氯丙嗪作用机制为阻断D[XB1.gif]、D[XB2.gif]受体。",
                                    "TestPoint": "抗精神失常药",
                                    "Answer": "D",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        }
                    ]
                }
            ]
        },
        "isVip": 0,
        "testInfo": [
            {
                "AllTestID": 43000504,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43000504,
                        "ChildTableID": -1,
                        "UserCount": 2406,
                        "RightCount": 1339,
                        "FavCount": 60,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 27
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43000504,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 27
            },
            {
                "AllTestID": 43000505,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43000505,
                        "ChildTableID": -1,
                        "UserCount": 2166,
                        "RightCount": 1607,
                        "FavCount": 37,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 12
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43000505,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 12
            },
            {
                "AllTestID": 43002631,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002631,
                        "ChildTableID": -1,
                        "UserCount": 2179,
                        "RightCount": 1502,
                        "FavCount": 51,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 22
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002631,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 22
            },
            {
                "AllTestID": 43002632,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002632,
                        "ChildTableID": -1,
                        "UserCount": 2054,
                        "RightCount": 1868,
                        "FavCount": 15,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002632,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 43002633,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002633,
                        "ChildTableID": -1,
                        "UserCount": 2370,
                        "RightCount": 1121,
                        "FavCount": 78,
                        "DiscussionCount": 1,
                        "ExplainCount": 0,
                        "ConcernCount": 19
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002633,
                    "ChildTableID": -1
                },
                "DiscussionCount": 1,
                "ExplainCount": 0,
                "ConcernCount": 19
            },
            {
                "AllTestID": 43002634,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002634,
                        "ChildTableID": -1,
                        "UserCount": 2109,
                        "RightCount": 1208,
                        "FavCount": 75,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 32
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002634,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 32
            },
            {
                "AllTestID": 43002636,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [
                        {
                            "AppID": 1328,
                            "AllTestID": 43002636,
                            "ChildTableID": -1,
                            "Answer": "A",
                            "AnswerCount": 1
                        }
                    ],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002636,
                        "ChildTableID": -1,
                        "UserCount": 2083,
                        "RightCount": 1367,
                        "FavCount": 51,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 12
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002636,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 12
            },
            {
                "AllTestID": 43002637,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002637,
                        "ChildTableID": -1,
                        "UserCount": 2087,
                        "RightCount": 1277,
                        "FavCount": 57,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 18
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002637,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 18
            },
            {
                "AllTestID": 43002638,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002638,
                        "ChildTableID": -1,
                        "UserCount": 2059,
                        "RightCount": 1215,
                        "FavCount": 65,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 15
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002638,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 15
            },
            {
                "AllTestID": 43002639,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002639,
                        "ChildTableID": -1,
                        "UserCount": 2033,
                        "RightCount": 1240,
                        "FavCount": 48,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 14
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002639,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 14
            },
            {
                "AllTestID": 43015416,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015416,
                        "ChildTableID": -1,
                        "UserCount": 1694,
                        "RightCount": 1633,
                        "FavCount": 5,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015416,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            },
            {
                "AllTestID": 43015417,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015417,
                        "ChildTableID": -1,
                        "UserCount": 1853,
                        "RightCount": 1426,
                        "FavCount": 21,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 8
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015417,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 8
            },
            {
                "AllTestID": 43015418,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015418,
                        "ChildTableID": -1,
                        "UserCount": 1923,
                        "RightCount": 1155,
                        "FavCount": 51,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 13
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015418,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 13
            },
            {
                "AllTestID": 43015419,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015419,
                        "ChildTableID": -1,
                        "UserCount": 1756,
                        "RightCount": 1442,
                        "FavCount": 37,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 10
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015419,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 10
            },
            {
                "AllTestID": 43015420,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015420,
                        "ChildTableID": -1,
                        "UserCount": 1814,
                        "RightCount": 1258,
                        "FavCount": 37,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 14
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015420,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 14
            },
            {
                "AllTestID": 43015422,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015422,
                        "ChildTableID": -1,
                        "UserCount": 1805,
                        "RightCount": 1306,
                        "FavCount": 33,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 20
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015422,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 20
            },
            {
                "AllTestID": 41000515,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 41000515,
                        "ChildTableID": -1,
                        "UserCount": 1788,
                        "RightCount": 1616,
                        "FavCount": 9,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 8
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 41000515,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 8
            },
            {
                "AllTestID": 35000550,
                "ChildTableID": 35000122,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 35000550,
                        "ChildTableID": 35000122,
                        "UserCount": 2054,
                        "RightCount": 1096,
                        "FavCount": 68,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 23
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 35000550,
                    "ChildTableID": 35000122
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 23
            },
            {
                "AllTestID": 35000550,
                "ChildTableID": 35000123,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 35000550,
                        "ChildTableID": 35000123,
                        "UserCount": 1811,
                        "RightCount": 1542,
                        "FavCount": 21,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 13
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 35000550,
                    "ChildTableID": 35000123
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 13
            },
            {
                "AllTestID": 41000517,
                "ChildTableID": 41000157,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 41000517,
                        "ChildTableID": 41000157,
                        "UserCount": 2094,
                        "RightCount": 1262,
                        "FavCount": 69,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 11
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 41000517,
                    "ChildTableID": 41000157
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 11
            },
            {
                "AllTestID": 41000517,
                "ChildTableID": 41000158,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 41000517,
                        "ChildTableID": 41000158,
                        "UserCount": 2190,
                        "RightCount": 1031,
                        "FavCount": 92,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 15
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 41000517,
                    "ChildTableID": 41000158
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 15
            },
            {
                "AllTestID": 41000518,
                "ChildTableID": 41000159,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 41000518,
                        "ChildTableID": 41000159,
                        "UserCount": 1993,
                        "RightCount": 1030,
                        "FavCount": 64,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 16
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 41000518,
                    "ChildTableID": 41000159
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 16
            },
            {
                "AllTestID": 41000518,
                "ChildTableID": 41000160,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 41000518,
                        "ChildTableID": 41000160,
                        "UserCount": 1914,
                        "RightCount": 1087,
                        "FavCount": 64,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 21
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 41000518,
                    "ChildTableID": 41000160
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 21
            },
            {
                "AllTestID": 41000519,
                "ChildTableID": 41000161,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 41000519,
                        "ChildTableID": 41000161,
                        "UserCount": 1842,
                        "RightCount": 1235,
                        "FavCount": 40,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 12
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 41000519,
                    "ChildTableID": 41000161
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 12
            },
            {
                "AllTestID": 41000519,
                "ChildTableID": 41000162,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 41000519,
                        "ChildTableID": 41000162,
                        "UserCount": 1929,
                        "RightCount": 923,
                        "FavCount": 57,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 15
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 41000519,
                    "ChildTableID": 41000162
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 15
            },
            {
                "AllTestID": 41000519,
                "ChildTableID": 41000163,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 41000519,
                        "ChildTableID": 41000163,
                        "UserCount": 1788,
                        "RightCount": 1216,
                        "FavCount": 43,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 18
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 41000519,
                    "ChildTableID": 41000163
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 18
            },
            {
                "AllTestID": 43002630,
                "ChildTableID": 43000681,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002630,
                        "ChildTableID": 43000681,
                        "UserCount": 1683,
                        "RightCount": 1338,
                        "FavCount": 18,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 8
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002630,
                    "ChildTableID": 43000681
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 8
            },
            {
                "AllTestID": 43002630,
                "ChildTableID": 43000682,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002630,
                        "ChildTableID": 43000682,
                        "UserCount": 1864,
                        "RightCount": 1016,
                        "FavCount": 54,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 16
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002630,
                    "ChildTableID": 43000682
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 16
            },
            {
                "AllTestID": 43015414,
                "ChildTableID": 43002839,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015414,
                        "ChildTableID": 43002839,
                        "UserCount": 1623,
                        "RightCount": 1272,
                        "FavCount": 20,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015414,
                    "ChildTableID": 43002839
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43015414,
                "ChildTableID": 43002840,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015414,
                        "ChildTableID": 43002840,
                        "UserCount": 1593,
                        "RightCount": 1247,
                        "FavCount": 22,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 6
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015414,
                    "ChildTableID": 43002840
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 6
            },
            {
                "AllTestID": 43015414,
                "ChildTableID": 43002841,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015414,
                        "ChildTableID": 43002841,
                        "UserCount": 1574,
                        "RightCount": 1334,
                        "FavCount": 15,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 4
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015414,
                    "ChildTableID": 43002841
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 4
            }
        ],
        "info": [],
        "encoded": 1,
        "examHistoryID": 0,
        "yimoinfo": [],
        "UserTime": 0
    },
    "status": 200
}